https://www.ukmlarevision.co.uk/ 2026-04-18 weekly 1.0 https://www.ukmlarevision.co.uk/ukmla-revision 2026-04-18 weekly 0.9 https://www.ukmlarevision.co.uk/ukmla-questions 2026-04-18 weekly 0.9 https://www.ukmlarevision.co.uk/subscribe 2026-04-18 monthly 0.8 https://www.ukmlarevision.co.uk/blog 2026-04-18 weekly 0.8 https://www.ukmlarevision.co.uk/blog/how-to-pass-the-ukmla 2026-04-18 monthly 0.7 https://www.ukmlarevision.co.uk/blog/plab-1-revision-guide 2026-04-18 monthly 0.7 https://www.ukmlarevision.co.uk/blog/sba-technique 2026-04-18 monthly 0.7 https://www.ukmlarevision.co.uk/blog/ukmla-content-map 2026-04-18 monthly 0.7 https://www.ukmlarevision.co.uk/blog/ukmla-revision-complete-guide 2026-04-18 monthly 0.8 https://www.ukmlarevision.co.uk/blog/ukmla-questions-guide 2026-04-18 monthly 0.8 https://www.ukmlarevision.co.uk/plab-1-revision 2026-04-18 weekly 0.9 https://www.ukmlarevision.co.uk/plab-1-questions 2026-04-18 weekly 0.9 https://www.ukmlarevision.co.uk/plab-1-question-bank 2026-04-18 weekly 0.9 https://www.ukmlarevision.co.uk/blog/plab-1-revision-complete-guide 2026-04-18 monthly 0.8 https://www.ukmlarevision.co.uk/blog/plab-1-questions-guide 2026-04-18 monthly 0.8 https://www.ukmlarevision.co.uk/blog/plab-1-vs-ukmla 2026-04-18 monthly 0.7 https://www.ukmlarevision.co.uk/blog/best-plab-1-question-banks 2026-04-18 monthly 0.7 https://www.ukmlarevision.co.uk/conditions/aa-amyloidosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/ace-inhibitor-side-effects 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/abdominal-aortic-aneurysm 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/acanthamoeba-keratitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/access-to-medical-records 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/achalasia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/acne-vulgaris 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/acoustic-neuroma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/acute-angle-closure-glaucoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/acute-coronary-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/acute-epiglottitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/acute-kidney-injury 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/acute-limb-ischaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/acute-liver-failure 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/acute-lymphoblastic-leukaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/acute-myeloid-leukaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/acute-otitis-media 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/acute-pancreatitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/addison-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/advance-decisions-and-lasting-power-of-attorney 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/age-related-macular-degeneration 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/alcohol-use-disorder 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/alcohol-related-depression 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/alcoholic-liver-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/alzheimers-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/amblyopia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/anaemia-of-chronic-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/anal-fissure 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/angina-pectoris 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/angioedema 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/ankylosing-spondylitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/anorexia-nervosa 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/anterior-uveitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/antiphospholipid-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/anxiety 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/aortic-dissection 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/aortic-stenosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/aphthous-ulcers 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/aplastic-anaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/appendicitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/ascending-cholangitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/asthma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/atopic-eczema 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/atrial-fibrillation 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/autoimmune-haemolytic-anaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/autosomal-dominant-polycystic-kidney-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/back-pain 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/bacterial-conjunctivitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/bacterial-keratitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/bacterial-meningitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/bacterial-vaginosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/basal-cell-carcinoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/bells-palsy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/benign-paroxysmal-positional-vertigo 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/benign-prostatic-hyperplasia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/beta-thalassaemia-major 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/biliary-colic 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/bipolar-disorder 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/bladder-cancer 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/bowel-obstruction 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/breast-cancer 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/breast-cancer-screening 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/breast-cyst 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/breast-surgery-complications 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/bronchiolitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/bulimia-nervosa 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/burns 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/copd 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/cancer-pain-management 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/carcinoid-tumour 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/cardiac-arrest 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/cardiac-tamponade 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/cellulitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/central-retinal-artery-occlusion 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/cervical-carcinoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/cervical-spondylosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/chalazion 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/child-development-motor-milestones 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/chlamydia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/cholecystitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/cholelithiasis-gallstones 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/chronic-fatigue-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/chronic-kidney-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/chronic-lymphocytic-leukaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/chronic-myeloid-leukaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/chronic-obstructive-pulmonary-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/chronic-pancreatitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/clostridium-difficile 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/clostridium-difficile-infection 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/clozapine-monitoring 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/coeliac-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/colorectal-cancer 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/colorectal-carcinoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/community-acquired-pneumonia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/complete-heart-block 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/confidentiality 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/conjunctivitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/consent 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/consent-in-young-people 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/cor-pulmonale 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/corneal-ulcer 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/croup 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/cushings-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/de-quervains-tenosynovitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/de-quervains-thyroiditis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/deep-vein-thrombosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/dehydration 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/delirium 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/dementia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/dental-abscess 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/depression 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/depressive-disorder 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/dermatomyositis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/developmental-delay 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/diabetic-ketoacidosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/diabetic-nephropathy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/diabetic-retinopathy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/dilated-cardiomyopathy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/disseminated-gonococcal-infection 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/disseminated-intravascular-coagulation 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/drug-induced-gingival-hyperplasia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/duty-of-candour 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/dysfunctional-uterine-bleeding 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/dyspnoea-in-palliative-care 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/ectopic-pregnancy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/eczema 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/emergency-contraception 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/emotionally-unstable-personality-disorder 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/endocarditis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/endometrial-cancer 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/endometrial-carcinoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/endometriosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/epiglottitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/epilepsy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/epistaxis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/erectile-dysfunction 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/erythema-multiforme 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/essential-hypertension 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/falciparum-malaria 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/falls-in-older-people 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/falls-in-the-elderly 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/fatty-liver-disease-nafld 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/febrile-convulsion 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/fibroids-uterine-leiomyoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/fibromyalgia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/first-episode-psychosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/fitness-to-practise 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/folic-acid-supplementation-in-pregnancy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/foreign-body-in-ear 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/frailty 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/gastric-cancer 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/gastric-carcinoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/gastro-oesophageal-reflux-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/generalised-anxiety-disorder 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/genital-herpes 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/genital-warts 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/giant-cell-arteritis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/gillick-competence 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/glomerulonephritis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/gonorrhoea 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/goodpastures-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/gout 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/granulomatosis-with-polyangiitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/graves-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/guillain-barr-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/gynaecomastia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hellp-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hiv 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/haemolytic-anaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/haemolytic-disease-of-the-newborn 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/haemolytic-uraemic-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/haemophilia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/haemorrhoids 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/health-inequalities 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hearing-loss 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/heart-failure 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/heart-failure-with-preserved-ejection-fraction 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/heart-failure-with-preserved-ejection-fraction-hfpef 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/heat-stroke 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/heavy-menstrual-bleeding 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/henoch-schnlein-purpura 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/heparin-induced-thrombocytopenia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hepatitis-b 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hepatitis-c 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hepatocellular-carcinoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/herpes-simplex-virus 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/herpes-zoster 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hip-fracture 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hodgkin-lymphoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hodgkins-lymphoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/human-immunodeficiency-virus 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hypercalcaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hypercalcaemia-of-malignancy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hyperemesis-gravidarum 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hyperkalaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hyperparathyroidism 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hypersensitivity-pneumonitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hypertension 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hypertensive-emergency 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hyperthyroidism 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hypertrophic-cardiomyopathy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hyperventilation-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hypoglycaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hyponatraemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hypoparathyroidism 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hypopituitarism 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hypothalamic-amenorrhoea 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hypothermia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/hypothyroidism 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/idiopathic-intracranial-hypertension 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/idiopathic-pulmonary-fibrosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/iga-nephropathy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/iga-vasculitis-henoch-schnlein-purpura 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/imaging-interpretation 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/immune-thrombocytopenic-purpura 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/immunisation-schedule 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/impetigo 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/infectious-mononucleosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/infective-endocarditis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/inflammatory-bowel-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/inguinal-hernia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/insomnia-disorder 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/interstitial-lung-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/intraductal-papilloma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/intussusception 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/iron-deficiency-anaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/irritable-bowel-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/kidney-stones 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/lambert-eaton-myasthenic-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/laryngeal-carcinoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/laryngitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/lateral-epicondylalgia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/lateral-epicondylitis-tennis-elbow 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/leukaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/leukaemia-acute-lymphoblastic 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/leukaemia-acute-myeloid 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/leukaemia-chronic-lymphocytic 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/leukaemia-chronic-myeloid 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/lichen-planus 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/liver-cirrhosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/low-back-pain 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/lung-cancer 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/lymphoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/lymphoma-non-hodgkins 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/mrsa 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/macular-degeneration 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/malaria 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/malignant-hyperthermia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/malignant-melanoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/mastalgia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/mastitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/melanoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/meningitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/meningococcal-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/meningococcal-septicaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/mental-capacity-act 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/mental-health-act 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/metastatic-bone-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/migraine-and-combined-oral-contraceptive-pill 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/mitral-stenosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/molar-pregnancy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/motor-neurone-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/multiple-myeloma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/multiple-sclerosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/myasthenia-gravis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/myocarditis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/nasal-polyps 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/nasopharyngeal-carcinoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/nephrolithiasis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/nephrotic-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/neuroleptic-malignant-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/normal-pressure-hydrocephalus 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/number-needed-to-treat 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/obesity 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/obstetric-cholestasis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/obstructive-sleep-apnoea 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/oesophageal-cancer 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/oesophageal-carcinoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/oesophageal-varices 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/open-angle-glaucoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/oral-cancer 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/orbital-cellulitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/orthostatic-hypotension 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/osteoarthritis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/osteomalacia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/osteoporosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/otitis-externa 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/otitis-media 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/ovarian-cancer 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/ovarian-cyst 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/overactive-bladder 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/paget-disease-of-bone 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pagets-disease-of-bone 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/palliative-care-symptom-management 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pancreatic-cancer 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pancreatitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/panic-disorder 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/paracetamol-overdose 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/paracetamol-poisoning 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/parkinsons-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pelvic-inflammatory-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/peptic-ulcer-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pericarditis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/periductal-mastitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/peripheral-arterial-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/peripheral-neuropathy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/peritonitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/peritonsillar-abscess 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pernicious-anaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pityriasis-rosea 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/placental-abruption 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/plantar-fasciitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pleural-effusion 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pneumonia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pneumothorax 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/polycystic-kidney-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/polycystic-ovary-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/polycythaemia-vera 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/polymyalgia-rheumatica 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/polymyositis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/polypharmacy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/post-operative-urinary-retention 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/post-traumatic-stress-disorder 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/posterior-communicating-artery-aneurysm 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/postpartum-haemorrhage 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/postpartum-thyroiditis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pre-eclampsia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pressure-ulcers 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/prevention-primary-secondary-tertiary 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/primary-hyperparathyroidism 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/primary-open-angle-glaucoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/professionalism-and-fitness-to-practise 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/prolactinoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/psoriasis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/psoriatic-arthritis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/psychosis-first-episode 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pulmonary-embolism 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pulmonary-tuberculosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/pyloric-stenosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/randomised-controlled-trial 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/rapidly-progressive-glomerulonephritis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/reactive-arthritis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/refusal-of-treatment 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/renal-cell-carcinoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/renal-tubular-acidosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/retinal-artery-occlusion 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/retinal-detachment 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/rheumatoid-arthritis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/right-heart-failure 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/rosacea 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/rotator-cuff-injury 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/rotator-cuff-tear 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/siadh 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/safeguarding 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/scabies 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/schizophrenia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/scleritis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/screening-programmes 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/seborrhoeic-dermatitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/sensitivity-and-specificity 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/sepsis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/septic-arthritis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/sheehans-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/shoulder-dystocia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/sick-sinus-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/sickle-cell-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/sigmoid-volvulus 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/silicosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/sinusitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/sjgrens-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/small-bowel-obstruction 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/social-anxiety-disorder 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/spinal-anaesthesia-complications 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/splenomegaly 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/spontaneous-bacterial-peritonitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/squamous-cell-carcinoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/status-epilepticus 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/stevens-johnson-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/stroke 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/subacromial-impingement 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/subarachnoid-haemorrhage 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/subdural-haematoma 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/suicidal-ideation 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/supraventricular-tachycardia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/syncope 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/syphilis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/systemic-lupus-erythematosus 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/systemic-sclerosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/tardive-dyskinesia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/telogen-effluvium 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/testicular-cancer 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/testicular-torsion 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/thalassaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/thyroid-cancer 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/thyroid-eye-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/thyroid-nodule 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/thyroiditis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/tinea-infections 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/tinnitus 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/tonsillitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/transient-ischaemic-attack 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/trichomonas-vaginalis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/tricyclic-antidepressant-overdose 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/trigger-finger 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/tuberculosis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/type-1-diabetes-mellitus 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/type-2-diabetes-mellitus 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/ulcerative-colitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/ulnar-nerve-palsy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/urinary-incontinence 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/urinary-tract-infection 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/urticaria 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/uterine-fibroids 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/varicocele 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/vasculitis 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/vasovagal-syncope 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/ventricular-fibrillation 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/ventricular-septal-defect 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/vertigo 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/volvulus 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/von-willebrand-disease 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/vulval-cancer 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/waldenstroms-macroglobulinaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/waldenstrm-macroglobulinaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/waldenstrms-macroglobulinaemia 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/warfarin-overdose 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/wernickes-encephalopathy 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/wolff-parkinson-white-syndrome 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/wound-infection 2026-04-18 monthly 0.6 https://www.ukmlarevision.co.uk/conditions/zollinger-ellison-syndrome 2026-04-18 monthly 0.6